Outlook on Norfolk Southern Corp Revised to Negative from Stable; Ratings Affirmed Oct 99

  • ID: 1928412
  • October 1999
  • Region: Norfolk Islands
  • Standard & Poors
1 of 3


  • Norfolk Southern Corp.
  • MORE

NEW YORK (Standard & Poor's CreditWire) Oct. 28, 1999--Standard & Poor's today affirmed its ratings on Norfolk Southern Corp. and its subsidiaries. The outlook is revised to negative from stable. The outlook revision reflects significantly worse than expected results following the company's June 1, 1999, assumption of control of its 58% ownership of Conrail, Inc. Initial computer information system, network management, and customer interface problems created delays and congestion. The company estimates that approximately $73 million of third quarter 1999 revenue was diverted to other modes of transportation, particularly trucking. Congestion-related expenses were of a similar amount. Norfolk Southern has made progress since June 1 in correcting these operational and information technology problems. However the initial setbacks and likely gradual...

Companies mentioned in this report are: Norfolk Southern Corp.
Action: Outlook Revised

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

Norfolk Southern Corp.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.